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ABSTRACT 
Plasmodium falciparum is an intracellular protozoan parasite that has been associated with 
humans since the dawn of time and causes severe forms of malaria. It is a major health problem 
around the globe and causes highest toll of death among children less than five years of age in 
developing countries. An infected female Anopheles mosquito injects malaria sporozoites into the 
skin while taking a blood meal. The sporozoites, which are released into the blood stream, 
reaches the liver where they undergo exoerythrocytic schizogony. After exoerythrocytic 
schizogony, millions of merozoites are released into the blood stream and infect new red blood 
cells, where they undergo erythrocytic schizogony in a cyclic manner. The erythrocytic schizogony 
stage of Plasmodium life cycle is where all clinical manifestations of malaria as a disease become 
apparent. The clinical symptoms like fever, headache, jaundice, vomiting have been associated 
with hyperparasitemia and these clinical symptoms coincide with the cyclical release of malaria 
parasites during schizonts rupture. A severe form of malaria develops as a consequence of 
capillaric sequestration of parasitized red blood cells (pRBC) and rosetting of pRBC with 
uninfected red blood cells which obstruct the blood flow to the brain. Activation of complement 
and coagulation, and increase in vascular permeability further aggravates severity of the disease 
which can lead to microcirculatory disturbances with comatous death as the ultimate outcome.  
 
Rupture of each Plasmodium falciparum infected red blood cell releases 8-32 infective merozoites 
along with a single digestive vacuole into the blood stream. The released digestive vacuole is an 
organelle in which hemozoin is surrounded by an intact membrane. We have discovered that the 
digestive vacuoles have the capacity to dually activate the complement and coagulation systems. 
Activation of complement and coagulation requires an intact DV membrane. The complement and 
coagulation activating properties of the DV are inhibited by low molecular weight dextran sulfate. 
In non-immune serum, DVs are opsonised with complement C3b and rapidly phagocytosed by 
polymorphonuclear granulocytes (PMN). Upon rupture, DVs lost its functional activities and the 
extracted malaria pigment from the DV organelle is not engulfed by the PMN. Liberated 
merozoites are not opsonized in non-immune serum and escape phagocytosis. High titered anti-
malarial antibodies from immune patients mediate some uptake of the merozoites, but to an 
extent that is not sufficient to markedly reduce re-invasion rates. Engulfment of DVs by PMN 
induces a respiratory burst, but the generated reactive oxygen species (ROS) are unable to 
suppress the infective capacity of invading merozoites. Finally, ingested DVs drive the PMN into a 
state of functional exhaustion. Upon challenging of PMN with bacteria after DV ingestion, the 
ability to phagocytose bacteria prevails, but their capacity to mount a respiratory burst is reduced 
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and microbicidal activity is compromised. We propose that these events might be linked to the 
development of septicemic episodes in patients with severe malaria in sub-Saharan African 
countries.  
 
ZUSAMMENFASSUNG 
Die lebensbedrohliche Form der Malaria wird durch Plasmodium falciparum verursacht und geht 
einher mit schwerwiegenden Störungen des Gerinnungs- und Komplementsystems- Bei der 
Ruptur eines infizierten Erythrozyten werden 8 bis 32 Merozoiten und eine Nahrungsvakuole in 
die Blutbahn freigesetzt. Die Nahrungsvakuole (digestive vacuole = DV) ist ein membranumhülltes 
Organell, in dem das Abbauprodukt des Hämoglobins, das sog. Hämozoin, verpackt ist. Die 
Dissertationsarbeit befasst sich mit bislang unbekannten biologischen Eigenschaften der DV. Wir 
haben entdeckt, dass das freigesetzte Organell die bemerkenswerte Fähigkeit besitzt, den 
intrinsischen Gerinnungsweg und das Komplementsystem simultan zu aktivieren. Beide Vorgänge 
lassen sich mit niedermolekularem Dextransulfat inhibieren. Bindung von C3b bewirkt, dass DVs 
von neutrophilen Granulozyten selektiv phagozytiert werden. Die Phagozyten werden dabei 
aktiviert und es kommt zur Bildung von reaktiven Sauerstoffradikalen. Dieses treibt die Zellen in 
einen hypofunktionellen Zustand: während ihre Phagozytosefunktion erhalten bleibt, können 
aufgenommene Bakterien nicht mehr effizient abgetötet werden. Die DV stellt möglicherweise 
einen neuen Pathogenitätsfaktor des Malariaparasiten dar und könnte unmittelbar für  
tiefgreifende Störungen des Gerinnungssystems und des natürlichen Immunsystems 
verantwortlich sein. 
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Introduction 
1. INTRODUCTION 
1.1 Historical outline 
Malaria is an ancient disease that has been associated with humans since the dawn of time. For 
thousands of years malaria was attributed to the inhalation of noxious vapours or miasmas from 
wetlands, and hence, the word malaria has been derived from Italian “Mal Air" meaning bad air. 
Malaria antigens were detected in the skin and lungs of Egyptian mummies from 3200 and 1304 
B.C. (Miller et al. 1994). Ancient accounts of malaria date back to Vedic writings of 1600 B.C. and 
autumnal fevers were referred to as “king of diseases” described from Vedic period in India. 
Tertian and quaternary fevers along with other malaria symptoms were also described in Chinese 
medical classic Nei-ching (Bruce-Chwatt et al. 1988). The great Greek physician Hippocrates (400 
BC) characterized malaria as a disease with intermittent and periodic fevers, and he considered it 
was connected to living in proximity to marshes. The descriptions in Roman medical literature also 
describes about malaria that it was associated with stagnant water and led the Romans to 
develop drainage programmes which was the first documented preventive measure against 
malaria. In the book Little House on the Prairie, Laural Ingalls Wilder clearly described the impact 
of malaria on the history of United States and it is commonly known as “fever and ague”. By the 
early eighteenth century, malaria was distributed worldwide due to growing population and 
increased movement of people across the globe. 
By seventeenth century, the research on malaria was further extended. Thomas Sydenham (1624-
1689) studied the differences in the periodicity of malaria fever and described clinical 
manifestation of malaria in detail. In the middle of 17th century, the Peruvian bark known by the 
natives as “Quina –quina” was introduced to Europe. For the first time in England around 1660, 
Thomas Sydenham and Richard Morton (1637-1698) confirmed its efficacy against malaria fever. 
This Peruvian bark was later called Cinchona bark and contained the active anti-malarial agent 
quinine. 
 
1.2 Global Distribution 
Malaria is one of the world’s most widespread disease. According to the World Health 
Organisation (WHO) report on malaria in 2011, malaria is prevalent in 106 countries in the tropical 
and subtropical regions of world where Anopheles mosquitoes can thrive and multiply. Malaria is 
caused by five Plasmodium species that affect humans i.e. P. falciparum, P. vivax, P. Malariae, P. 
ovale, and P. knowlesi. Malaria due to P. falciparum is the most common and deadly in African 
countries. As temperature plays a vital role in Plasmodium falciparum below 20°C (68°F) it cannot 
complete life cycle in the Anopheles mosquito, and thus cannot be transmitted. Plasmodium vivax 
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Introduction 
is less dangerous but more prevalent because it can tolerate low ambient temperature (world 
malaria reports 2011). According to the world malaria report 2011, an estimated 3.3 billion 
people were at risk of malaria in 2010. Eighty one percent of malaria cases and 91% of deaths 
over the world were estimated to occur in African countries, children less than five years of age 
and pregnant women are being most severely affected. 
 
 
Figure 1. Global distribution of malaria: The intensity of malaria transmission and endemicity in 
different countries around the globe. Source: - World Malaria Report 2011. 
 
1.3 Taxonomy 
The Phylum Apicomplexan consists of a wide spectrum of eukaryotic organisms. It includes 
protozoan parasites that infect both humans and veterinary animals such as Plasmodium, 
Toxoplasma, Theileria, Eimeria, Cryptosporidium, and Babesia species. Laveran coined the name 
“Oscillaria malariaeˮ without knowing the biological function of the parasite, and he believed that 
flagellate bodies are more important stage (Laveran et al. 1881). Since the spores develop at the 
end of the life cycle, they have been classified in the Class Telosporea. Within the Class 
Telosporea, the Order Eucoccidiorida comprises parasite of red blood corpuscles of vertebrate 
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animals. Danilewsky observed similar parasite in the birds and he placed the parasites into new 
group Haemosporidia. The parasite is unable to pass any part of their life cycle outside the body 
of the host, so it belongs to the order Haemosporina in which they constitute the family 
Plasmodiidae. The family Plasmodiidae contains a single Genus Plasmodium that undergoes 
schizogony in the vertebrate host and sporogony in mosquito. 
There are about 200 species of Plasmodium, 22 of them infect primates. Five species infect 
humans: P. falciparum, P. Ovale, P. Vivax and P. malariae, P. knowlsi. Of these, P. falciparum is the 
deadliest and important in public health as it is the parasite responsible for the high mortality 
observed in malaria endemic regions. 
 
1.4 Life cycle 
The malaria parasite has a complex, multistage life cycle, which completes in two living organism, 
the invertebrate vector mosquito and the vertebrate host. Infection of the host is initiated by the 
bite of infected female Anopheles (=Greek; hurtful, harmful) mosquito. Invasive sporozoites 
(Greek; Sporos =seeds) contained in the mosquito’s saliva are inoculated into host skin. Following 
intradermal deposition of sporozoites, some are destroyed by local macrophages and other 
reaches the blood vessels. The sporozoites that reach a blood vessel infect the liver within few 
hours after infection. A mean of 15 sporozoites are inoculated (Rosenberg et al. 1990) and they 
remain in the circulation for 15-60 minutes (Sihden and Smith 1982) then sporozoites migrate into 
hepatocytes, where they undergo exo-erythrocytic schizogony within the parasitophorous 
vacuole. The entire pre-erythrocytic stage of the parasite lasts about 5-10 days depending on the 
parasite species, and thought to occur only once in the case of mammalian malaria parasite: on an 
average 5-6 days for P. falciparum, 9 days for P. ovale, 8 days for P. vivax, 13 days for P. malariae, 
and 8-9 days for P. knowlesi. In P.vivax malaria, some of the sporozoites develop dormant forms 
known as hypnozoites in the liver for months and infection can recur later causing relapses of 
clinical infection after few weeks to months. (Krotoski et al. 1982).  
The merozoites released from the liver into the circulation rapidly invade red blood cells, where 
they begin part of the life cycle called erythrocytic schizogony. Merozoites recognize, attach, and 
invade the red blood cell through the presence of species-specific receptors in/on erythrocyte 
membrane in as little as 60 seconds. P. vivax depends on two different ligands for its invasion into 
erythrocyte i.e. Duffy binding-like protein (DBP) that binds to Duffy blood group antigen (Miller et 
al. 1976) and reticulocyte homology protein that binds to unknown receptors on reticulocytes 
(Galinski et al. 1992). Plasmodium falciparum can use highly redundant and alternate invasive 
pathways that utilize several different receptors to enter the red blood cell. For example, P. vivax 
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has only one Duffy binding-like erythrocytic binding protein (DBL-EBP) family of gene, whereas P. 
falciparum has four DBL-EBP genes (Mayer et al. 2009). It has been known that some species of 
malaria parasite preferentially infects young erythrocytes. An in vitro study shows that P. berghei 
preferentially infects reticulocytes (McNally et al. 1992). Similarly, P. vivax has preference for 
infection of reticulocytes (Garnhamet et al. 1966) and in P.falciparum reticulocytes and young RBC 
are more susceptible than old RBC (Pasvol et al. 1980). 
Within the RBC, the merozoite develops into ring form, trophozoite stages, and the nucleus 
divides asexually to form a schizont containing between 8-32 merozoites. The erythrocytic 
schizogony occurs every 48 hours in case of P. falciparum, P. ovale, P. vivax, and 72 h in case of P. 
malariae, while in P.knowlesi it lasts 24 hours. Finally, the rupture of erythrocytic schizont 
releases new merozoites which invade new RBC. The parasite density can rise rapidly to the level 
as high as 1013 per host (Greenwood et al. 2008).  
A small fraction of merozoites differentiate into male or female gametocytes. Gametocytes may 
be rounded or banana/crescent in shape depending on the species. Gametocytes complete their 
sexual life cycle in the female mosquito. Most female mosquitoes have to feed on animals and get 
sufficient blood meal as a protein source to nourish their eggs and lay 30-150 eggs every 2-3 days. 
Mature female and male gametocytes ingested by the mosquito reach the mid gut of the insect, 
where the male gametocyte undergoes a rapid process of DNA replication and nuclear 
segmentation. The progression from haploid genome to octaploid genome with the formation 
and migration of eight nuclei into highly motile, flagellated microgametes is called exflagellation 
(Janse et al. 1986a; Janse et al. 1986b). This process is completed within 10 to 20 minutes after 
ingestion of blood meal. Fertilization of female gametes by free swimming male gametes leads to 
formation of the zygote. Gametogenesis, formation of male and female gametocytes and 
exflagellation of male gametes is triggered mainly by drop in temperature (Ogwan'g et al. 1993; 
Billker et al. 1997) accompanying the transition from warm-blood host to the mosquito gut. 
Change in pH, carbon-dioxide tension (Carter and Nijhout 1977), and mosquito mid gut factors 
(Billker et al. 1997; Garcia et al. 1997) also significantly contribute to the induction of 
gametogenesis. 
The zygote develops into elongated slowly motile ookinete which actively penetrates the gut 
epithelial cells and develops into an oocyst. The oocyst undergoes multiple rounds of asexual 
replication leading to formation of as many as 10,000 new individual nuclei within a mature 
oocyst of 40 to 60 µm in diameter. The time required for the establishment of mature oocyst from 
initial zygote depends on the parasite species, the Anopheline species, and on the ambient 
temperature: it varies from 7 to 30 days. The products of the mature oocyst are the sporozoites, 
which are narrow, curved in shape, actively motile and 10-15 μm in length. Rupture of the mature 
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oocyst releases the sporozoites into the haemocelomic space of the mosquito. The sporozoite 
migrates and reaches the salivary glands, where it penetrates the basal membrane and settles in 
the salivary duct, thus completing the life cycle (Lobo and Kumar 1998). 
 
 
Figure 2. Life cycle of the human malaria parasite: Both the sexual and asexual phase of the life 
cycle, alternating between the mosquito and human hosts are shown. First, the sporozoites are 
injected by the infected mosquito into the skin, and reach the liver, where they differentiate into 
merozoites. Second, after exoerythrocytic schizogony, merozoites enter the blood stream and 
infect new red blood cells and continuous erythrocytic schizogony. Source: - Ménard, R (2005). 
Medicine: Knockout malaria vaccine? Nature 433, 113-114.  
 
1.5 Ultrastructures of different stages of the erythrocytic cycle 
The merozoite stage 
The free invasive merozoite is very small, <1.6 mm long and 1.0 mm wide, ovoid in shape with a 
low, flat ended projections at one end (the apical prominence) (Langreth et al. 1978). The apex 
contains three sets of secretory vesicles used in invasion and these are; a pair of rhoptries, 
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numerous small micronemes and small rounded dense granules. The nucleus is placed basally and 
a plastid and a mitochondrion lie along one side of the merozoite (Bannister et al. 2000a). The 
merozoite coat is made up of merozoite surface protein (MSP) 1 which comprises most abundant 
protein of the merozoite coat and it is known to be cleaved during invasion (Holder 1994). After 
invasion, the dense granule releases their contents in to the parasitophorous vacuole and 
increases the area of its membrane (Culvenor et al. 1991), and probably facilitates the change in 
shape of the parasite to the ring stage (Bannister et al. 2000a). 
 
 
 
 
 
Figure 3. Three-dimensional organization of a Plasmodium falciparum merozoite, with the pellicle 
partly cut away to show the internal structure. Source: - Bannister et al. (2000). A brief illustrated 
guide to the ultrastructure of Plasmodium falciparum asexual blood stages. Parasitol. Today,  16: 
427–433. 
The ring stage 
After invasion the parasite morphs itself into a thin discoid, flat or cup-shaped ring form (Langreth 
et al. 1978). At the early ring stage the parasite starts importing haemoglobin through a small 
dense ring on the surface of the parasite called “cytostomeˮ (Slomianny 1990) and feeds on 
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haemoglobin. Through the cytostome, a small digestive vacuole with RBC cytosol forms by 
pinching off the parasitophorous vacuole membrane (PVM) and the plasma membrane of the 
parasite (Slomianny 1990). The free haem resulting from haemoglobin digestion is converted into 
inert black-brown haemazoin pigment crystals that accumulate within the digestive vacuole 
throughout erythrocytic phage of the cycle. Initially these small vacuoles derived from 
endocytosis act as an individual digestive vacuole, but in later stages these vesicles fuse to from a 
single large digestive vacuole (Bannister et al. 2004). As the parasite matures the area of the PVM 
also increases and the parasite extends membranous structures into the surrounding medium, 
and finally changes its shape to round or irregular trophozoite (Elford et al. 1995). 
 
 
 
Figure 4. Three-dimensional structure of a Plasmodium falciparum early ring stage. Source: - 
Bannister et al. (2000). A brief illustrated guide to the ultrastructure of Plasmodium falciparum 
asexual blood stages. Parasitol. Today,  16: 427–433. 
Trophozoite stage 
The parasite feeds more actively on haemoglobin than the ring form and forms a large digestive 
vacuole in which the degradation products of haemoglobin (hemozoin crystals) accumulates. The 
parasite surface forms irregular bulges and deep tubular invaginations [Tubo-Vesicular Network 
(TVN)] within the host cell and some of these invaginations may extend out to the RBC surface 
(Trelka et al. 2000). These extended membranes structures called as Maurer’s clefts. There is 
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some evidence to suggest that these structures are involved to access large extracellular 
molecules from the parasite surface into the erythrocyte cytosol and perhaps vice versa, because 
some fluorescent dyes can readily penetrate to the parasite through the RBC (Pouvelle et al. 
1991), (Lauer et al. 1997). By the mid-trophozoite stage, the rough ER and putative Golgi complex 
have increased in size and complexity (Bannister et al. 2004). Parasite export proteins to the 
erythrocyte surface to form “knob” like structures in P. falciparum. The Knobs help P. falciparum 
trophozoite to strongly adhere to the endothelial cells of various tissues in the body. 
Sequestration of parasitized erythrocytes in the brain microvasculature blocks the blood supply to 
the brain, and drives the patient to comate state and leading to cerebral malaria, finally death 
(Ponsford et al. 2012). 
 
Figure 5. Plasmodium falciparum, trophozoite stage characterized by its irregular shape, the 
increased protein synthesis machinery, increased uptake of hemoblobin through multiple 
cytostomes, growth of the digestive vacuole, and structures associated with export of parasite 
proteins (Golgi body, exocytic vesicles). Source: - Bannister et al. (2000). A brief illustrated guide 
to the ultrastructure of Plasmodium falciparum asexual blood stages. Parasitol. Today,  16: 427–
433. 
The schizont stage                                    
The trophozoite undergoes repetitive nuclear division to become a schizont. Ingestion of 
hemoglobin lasts until late in the schizont stage and almost complete consumption of 
haemoglobin while adding further haemozoin crystals to the digestive vacuole. At the same time, 
the parasite exports proteins to the RBC continuously until the late schizont stage (Bannister et al. 
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2004). The exported proteins distort the RBC membrane to increase the number of knobs on the 
cell (Nagao et al. 2000). In P. falciparum the nucleus divides and produces 16- 32 merozoites. 
Nuclear division is endomitotic, a common feature in unicellular eukaryotes (Bannister et al. 
2000a). To form the merozoite, the cytoskeletal components including polar rings and microtubles 
are assembled beneath the merozoite surface and a cleavage furrow now forms around each 
nascent merozoite for defining its shape (Bannister et al. 2000b). Before complete separation, 
each merozoite gets a copy of mitochondrion and the plastid. After complete segregation from 
each other, the merozoites cluster within the PVM and they are released when the erythrocyte 
membrane and the PVM are ruptured. These last steps are triggered by secretions from the apical 
complex (Bannister 2001). Merozoite egression from the host erythrocyte has recently been 
shown to occur in a two step process (Salmon et al. 2001). Using GFP-tagged proteins it was 
shown that PVM ruptures first followed by a secondary rupture of the erythrocyte membrane. 
Selective inhibition of the two step escape process was achieved by using specific protease 
inhibitors (Wickham et al. 2003). 
 
Figure 6. Plasmodium falciparum infected RBC at the end of schizont stage, depicted in a schizont-
infected red blood cell, to show parasite and RBC structure, Maurer’s clefts, and surface knobs. 
Merozoites are maturing from the surface of the schizont and the apex of each merozoite 
contains apical organelles, and mitochondria (green) and plastids (yellow) are migrating into the 
buds. Source: - Bannister et al. (2000). A brief illustrated guide to the ultrastructure of 
Plasmodium falciparum asexual blood stages. Parasitol. Today,  16: 427–433. 
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1.6 Transmission 
The most important milestone in the malaria history was the discovery of malaria transmission. 
Laveran discovered the malaria parasite in 1880 and these findings were confirmed by Camillo 
Galgi, Marchiafav, Celli and many other researchers worldwide. Next, the researchers mainly 
focused on unravelling the mystery of malaria transmission. Laveran and Patrick Manson have 
demonstrated the role of mosquitoes in the transmission of filariasis while working in South China 
in 1878. Based his experience on filariasis, Manson speculated that mosquitoes could play a vital 
role in malaria transmission. Manson passed his experience and finding to his colleague Ronald 
Ross. Taking this cue, Ross initially used Culex and Aedes mosquitoes to study malaria 
transmission and infection but he was in vain. Ross was not an entomologist, so he classified the 
mosquitoes he was studying as gray or barred-back (Culex sp), brindled (Stegomyia sp) and 
dappled-winged (Anopheles sp) (Ross et al. 1923). He used avian malaria parasite Proteosoma 
relictum (now called Plasmodium relictum), commonly infects many species of birds including 
crows and sparrows and discovered that it was transmitted by ‘grey’ mosquitoes, probably Culex 
fatigans and published his observations in 1898. When he was working in Secunderabad, India on 
20 August 1897, he found pigmented bodies called rods that invade the mosquito’s salivary gland 
in the dapple-winged mosquito after being fed on a malaria patient and he called 20th August as 
“Mosquito Day” (Ross et al. 1923). Ross discovery was further confirmed by the Italian Scientists 
and proved that only female Anopheles mosquitoes could transmit malaria, and described the 
whole blood-mosquito life cycles of P. falciparum and P. malariae P. vivax, (Grassi et al. 1900). 
Ross was awarded Nobel Prize in 1902 for his discovery of Malaria transmission. 
 
1.7 Clinical symptoms  
Malaria infections are asymptomatic during the exoerythrocytic schizogony, and the clinical 
symptoms do not develop prior to the rupture of infected RBC. In 1886, Camillo Golgi was the first 
to identify that malaria fever coincides with the cyclical release of malaria parasites during 
schizonts rupture of red blood cells (Golgi et al. 1886). The mechanisms associated with P. 
falciparum infections are still completely not understood. Malaria infection may take a variety of 
clinical courses differing in pattern and severity. P. falciparum infected erythrocytes have 
decreased in deformability and sequester to the deep vascular system to escape from splenic 
clearance. Sequestration and high replication rates are thought to play a key role in falciparum 
malaria infection. The severity and outcome of the disease depends on age, and immune status of 
the patients. Several types of malaria fever have been described including intermittent, remittent, 
and continuous and some are symptomless, others are fatal. Malaria febrile paroxysms last for 5-6 
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hours and recur every 2- 3 days depending on parasite species and synchrony of the cycle. 
Plasmodium falciparum, P. ovale and P. vivax recurs each third day, while P. malariae recurs on 
every fourth day. The severity of the fever is always related to the rupture of mature schizonts 
and release of antigenic material into the bloodstream. Based on Ronald Ross and David 
Thomson’s observations, a minimum of 200 to 500 parasites per μl of blood in P. vivax patients 
and 600 to 1500 parasites per μl of blood in P. falciparum infected patients were necessary to 
induce fever (Ross et al. 1910). Patients with P. falciparum infections can develop organ bleeding, 
liver or kidney failure and central nervous system problems, which can lead to cerebral malaria 
and death. WHO recommends criteria to classify malaria infections. These criteria include the 
presence of the following complications: coma, renal failure, severe anemia, acidosis, respiratory 
distress syndrome, hypoglycaemia, bleeding, shock, intravascular haemolysis, convulsions, 
jaundice, and hyperparasitaemia. Severe anemia is very common among children in high malaria 
transmission regions (Snow et al. 1997). During pregnancy, the clinical symptoms of malaria may 
vary according to the level of endemicity. In holoendemic areas pregnant women with P. 
falciparum infections have higher parasitemia and more severe clinical symptoms than non-
pregnant women. Pregnancy malaria is associated with low birth weight babies and abortions 
{(Nosten et al. 1994).  
 
1.8 Malaria diagnosis  
Malaria is a preventable and treatable disease, must be diagnosed promptly in order to treat the 
patient within time. Delay in diagnosis and treatment of malaria can lead to death of the patient 
in non-endemic areas and non-immune patients. Diagnosis of malaria is difficult where malaria is 
not endemic, because the health-care providers may not be familiar with the disease. Clinical 
diagnosis gives initial information about the patient, which is based on the clinical symptoms and 
physical conditions of the patient at the time of examination. The first symptoms of malaria most 
often includes fever, chills, sweats, headache, muscle pains and vomiting, which are also 
symptoms of other diseases such as flu and viral fever. These clinical symptoms should be 
confirmed by one of the below mentioned laboratory test for malaria. 
Microscopic diagnosis 
Microscopic examination of peripheral blood smear is gold-standard for the confirmation of 
malaria. Thick and thin smears are prepared from the peripheral blood and stained with 
Romanovsky stain (most often Giemsa), and examined with a 100X oil immersion objective. These 
blood smears provide information on the species, the stage, and the density of parasitemia.  
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Quantitative buffy coat (QBC) technique  
The QBC test is a new method for identification of malaria parasite in peripheral blood. The QBC 
tube is high-precision glass hematocrit tube pre-coated internally with Acridine Orange and 
Potassium Oxalate. When QBC tube filled with blood from patient and centrifuged at 12,000 rpm 
for 5 min, blood cells separate according to their densities and form discrete bands. RBCs 
containing malaria parasite are less dense than normal blood cells and concentrate below the 
white blood cells at the top of the erythrocyte column. The fluorescing malaria parasites are 
observed from the red blood cell/white blood cell interface using a standard white light 
microscope equipped with the UV microscope adapter, an epi-illuminated microscope objective. 
The QBC method is easy and faster (20-30 minutes), but identification of the parasite species, and 
quantification of the parasitemia is difficult (Adeoye and Nga 2007). 
Antigen diagnosis 
A dipstick antigen detection test provides an attractive alternative method for diagnosis of 
malaria in the field studies, where staining and microscopy equipment are not easily available. 
These "Rapid Diagnostic Tests" (RDTs) offer a useful alternative to microscopy and are currently 
used in some clinical settings. Sensitivity and specificity of this method for the diagnosis of malaria 
infections are between 80% and 100% when compared with blood films (Heutmekers et al. 2012).  
Molecular diagnosis 
Polymerase chain reaction (PCR) is useful for the detection of species-specific Plasmodium 
genome and it is more sensitive than other tests, and can able to detect as few as 10 parasites/µl 
of blood sample. PCR is very expensive technique and difficult to take to the rural places, where 
malaria is more prevalent. Although quantitative PCR method has been described, the nested PCR 
is most widely used method for epidemiological and clinical research purpose (Singh et al. 1999). 
Clinical workers prepare the blood sample on a glass fiber membrane and dry the membranes, 
the dried blood spots are sent to the lab for PCR diagnosis (Curtis et al. 1998). The use of glass 
fiber membrane is very simple and the sensitivity is excellent, even though the use of filter paper 
reduces the sensitivity (Färnert et al. 1999). PCR has been regularly used successfully as a gold 
standard method for epidemiological purpose (Hänscheid and Grobusch 2002). 
1.9 Chemotherapy  
For nearly two centuries following its introduction, cinchona was largely dispensed as a powder 
prepared from the bark of Cinchona. In 1820, the French chemists Pelletier and Caventou isolated 
two alkaloids, which were named as quinine and cinchonine. Quinine was soon found to be a 
more reliable therapeutic agent for malaria treatment. In the middle of 18th century, Ledger found 
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some species of cinchona, which was found to have high quinine content and it was subsequently 
named Cinchona ledgeriana. It is less effective and potentially more toxic than chloroquine. 
Chloroquine is a prototype of 4-aminoquinolines anti-malaria drug, which also includes 
amodiaquine, a most widely used drug for all types of malaria fevers (McChesney 1983). The 
mechanism of action of chloroquine is not yet clear; at high concentration the drug reaches the 
digestive vacuole and inhibits the haemozoin formation by raising its pH. Primaquine, 8-
aminoquinoline inhibits the parasite at schizont stage and is useful to control schizonts in the 
tissues. In addition, these compounds inhibit parasite growth and effectively act against sexual 
forms of P. falciparum. The metabolic products of primaquine block electron transport disrupting 
the parasite's energy metabolism. Antifolate drugs, such as pyrimethamine, sulphadoxine block 
tetrahydrofolate biosynthesis, an important cofactor in the parasite's metabolism. Pyrimethamine 
is a competitive inhibitor of dihydrofolate reductase, while sulphadoxine blocks dihydropteroate 
synthetase. These anti malarial drugs also inhibit the parasite at schizont stage and are used in 
combination as a therapy in the case of chloroquine resistant P. falciparum infections. Mefloquine 
and halofantrine compounds have potent action against blood schizonts. Artemisin is an effective 
anti-malarial drug isolated from Artemisia annua. Artemether, artesunate and dihydroartemisin 
are the derivatives of artemisin and have more potent anti malarial activity than the parent 
compound. These compounds act most rapidly than all other antimalarials developed so far. They 
mainly act against schizonts but the mechanism of action is not completely understood. 
Atovaquone is a hydroxynaphthoquinone which has anti-protozoan activity. It has a novel mode 
of action by inhibiting electron transport in P.falciparum. 
Drug resistant parasites have been reported from most parts of the world as a result of mutations 
which are selected after frequent use of anti-malarial drugs. Now, new anti-malarial remedies are 
therefore urgently required. Anti-malarial combinations may increase efficacy of the treatment, 
decrease the duration of treatment and also decreases the development of drug resistant 
parasites. Combination therapy is the simultaneous use of two or more anti-malaria drugs with 
independent mode of anti-malarial activity. The concept of combination therapy is based on 
synergistic effect of two or more drugs and improves the therapeutic efficiency. Artemisinin 
based combinations are in clinical trials and are known to improve survival rates, reduce the 
development of resistance and they might decrease transmission of drug-resistant parasites 
(Nosten and White 2007), (Bosman and Mendis 2007), (Kamya et al. 2007).  
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1.10 The discovery of hemozoin  
The presence of black-brown pigment was first observed by German physician, Johann Heinrich 
Meckel in 1847, in the autopsy studies on the body of patient who had died from malaria. 
However, he did not make connection between the pigment and malaria. Rudolf Virchow, 
German pathologist in 1848 pictured and described the pigment in the blood of a patient infected 
with malaria and he is the one who first linked pigment to malaria. Hischel, in 1850, noticed and 
confirmed the connection between the presence of pigment and intermittent fevers. Planer, in 
1854, observed the pigment in the circulating blood. He suggested that the pigment in the 
circulating blood emanates during the fever and it causes many symptoms. Finally Laveran, a 
French military surgeon in 1880, discovered the fact that the pigment was mainly contained in the 
body of a living parasite. Councilman and Abbot, in 1885 performed autopsy studies on two cases 
of comatose pernicious malaria and described that pigment containing bodies in and outside of 
the red blood cell. They have mainly observed these pigmented bodies in the capillaries of the 
brain and also in the liver and spleen, as well as pigmented leukocytes. Golgi is the one who first 
photographed the pigmented malaria parasite (Sullivan 2002).                         
Hemozoin structure 
In the year 1847, a German Physician Johann Heinrich Meckel, discovered a black-brown pigment 
in an insane person and subsequently this was linked to malaria by the pathologist Rudolf Virchow 
in 1849 (Virchow et al. 1849). Initially this pigment was believed to be melanin and in 1911 WH 
Brown distinguished the malaria pigment from melanin using potassium permanganate bleaching 
technique (Brown et al. 1911). Later Gosh and Nath in 1934, Gosh and Sinton in 1934 have 
demonstrated that malaria pigment hemozoin and the alkaline preparations of hemozoin were 
identical to heme in the spectra (Gosh and Nath et al. 1934, Gosh and Sinton et al. 1934). Other 
groups (Ashong et al. 1989) speculated the necessity of proteins in the hemozoin formation and 
identified proteins that co purified with hemozoin. Two individual groups Fitch and 
Kanjananggulpan et al. (1987), Slater et al. (1991) confirmed that hemozoin contains only haem 
and not the proteins (Fitch and Kanjananggulpan 1987; Slater et al. 1991). By using infrared and X-
ray spectroscopy Slater et al. (1991) postulated that hemozoin contains iron-corboxylate bond 
between two haem monomers. Iron in the hemozoin crystals contains in the form of 3+ ferric 
states (Brémard et al. 1993) and it has paramagnetic properties (Nalbandian et al. 1995). By using 
X- ray powder diffraction method, Pagola et al. (Pagola et al. 2000) concluded that haemozoin 
contains Fe1-O41 head to tail heme dimers in the crystals rather than the step ladder polymers 
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(Slater et al. 1991) and the dimers form chains linked by hydrogen bonds in the crystal (Pagola et 
al. 2000).                                          
Slater and Cerami showed the conversion of iron(III) protoporphyrin IX (Fe(III)PPIX) to hemozoin 
under acidic (pH 5.5) conditions in the presence of parasite extract and postulated that heme 
polymerase is responsible for hemozoin formation (Slater and Cerami 1992). Formation of 
hemozoin under these conditions was inhibited by widely used anti-malarial quninolines. 
Afterwards, Egan et al., 1994; Dorn et al., 1995 have demonstrated the β-hematin formation in 
the test tube at 60-70° C in an excess molar concentration of acetate and millimolar 
concentrations of monomeric heme(Egan et al. 1994; Dorn et al. 1995). β-hematin has identical 
Fourier Transform Infrared absorbance peaks at 1,207 cm21 and 1,667 cm21, to hemozoin and 
both  have identical properties like, insolubility in water, basic solutions at pH 9 and also in 
dimethyl sulphoxide (DMSO) which normally solubilises protoporphyrins (Slater et al. 1991). 
Debate continues over a spontaneous chemical reactions or a parasite guided process in the 
digestive vacuole. Fitch et al., in 1999 have shown that lipid micelle can also form heme crystals 
in-vitro (Fitch et al. 1999) and in the parasite extracts from Plasmodium berghei (Chou and Fitch 
1992). In Goldbergs laboratory purified digestive vacuoles immunised to rabbits and the immune 
serum was used to screen cDNA library (Sullivan et al. 1996). Most of the clones were matched to 
previously characterised gene Pf histidine-rich protein (PfHRP) II. PfHRP II was shown to localize in 
the digestive vacuole and demonstrated that PfHRP II binds to heme at an acidic pH and initiates 
the hemozoin formation (Sullivan et al. 1996). Two other groups, Lynn et al., 1999; Papalexis et 
al., 2001 also independently showed that PfHRP II initiates crystals formation (Lynn et al. 1999), 
(Papalexis et al. 2001). Hemoglobin constitutes 95% of total cytosolic proteins of the red blood 
cell. During intraerythrocytic cycle of malaria parasite, the host hemoglobin is consumed and an 
estimated 70-80% of it is degraded (MORRISON and JESKEY 1948), (Orjih and Fitch 1993). 
Degradation of hemoglobin occurs via semi-ordered process by parasite proteases within the 
lysosome-like organelle, called digestive vacuole and releases heme and amino acids (Goldberg et 
al. 1990). The heme moiety is stored in the form of an inert polymer as malaria pigment hemozoin 
in the digestive vacuole (Sherman 1977).  
Digestive vacuole (DV) is a highly specialized organelle and is the primary site for hemoglobin 
degradation (Olliaro and Goldberg 1995). DVs in Plasmodium falciparum are acidic organelles with 
an estimated pH around 5.0-5.4 (Krogstad et al. 1985). Digestive vacuoles are formed by 
endocytosis from the parasite surface via cytostome. Cytostome is large double membrane 
invaginations of the parasitophorous vacuole membrane (PVM) and parasite plasma membrane 
(PPM) and contains electron dense material flanking around the cytostome (Langreth et al. 1978). 
Vesicles containing hemoglobin buds from the parasitophorous vacuole membrane (PVM) are 
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ingested through cytostome to from one or more digestive vacuoles and the PVM is subsequently 
degraded. (Aikawa et al. 1966; Slomianny et al. 1985; Slomianny 1990; Slomianny and Prensier 
1990; Lazarus et al. 2008; Dluzewski et al. 2008). Parasite starts importing hemoglobin in the early 
and mid ring stages through the double membrane vesicles. Each individual endocytic vesicle can 
import degradative enzymes from the parasite secretory pathways (Klemba et al. 2004) and can 
break down hemoglobin to forms hemozoin crystals (Klemba et al. 2004). Later these small DVs 
fuse to form a single large digestive vacuole, which eventually fills with hemozoin as the parasite 
grows (Bannister et al. 2004; Elliott et al. 2008). In the completely developed blood schizont, the 
DV remains a separate, distinct organelle, which is separated from the newly formed merozoites. 
Upon rupture each schizont releases one DV along with 16-32 infective merozoites into the blood 
stream. 
 
1.11 Immunity to malaria 
Natural malaria infections lead to only a partial and short lived immunity that is unable to 
completely protect the individual from new malaria infection. Children below five years of age are 
at highest risk of severe malaria and clinical symptoms generally become less severe are rare in 
adults. In low or unstable transmissions areas, immunity against malaria is not acquired and 
therefore all age groups are at high risk. 
Innate Immunity 
Natural immunity against malaria is an obstinate inherent of the host that prevents establishment 
of infection or an immediate inhibitory responses against the malaria at the beginning of 
infection. In high malaria transmission regions, individuals can be partially protected against 
malaria due to alterations in the structure of hemoglobin. For example, sickle cell anemia and 
beta-thalassaemia make more difficult for P. falciparum or P. vivax to invade red blood cells 
(Williams 2006). Glucose 6 phosphate dehydrogenase deficiency confers 50% protection against 
severe malaria infections (Carter and Mendis 2002; Doolan et al. 2009). Some people lack Duffy 
antigen in the red blood cells on their surface, which act as a receptor for Plasmodium vivax and 
so individuals without Duffy protein are resistant to P. vivax infection (Barnwell et al. 1989). 
Individual with acute malaria infections induces non-specific early immune responses, which limits 
the progression of disease. Tissue macrophages and dendritic cells (DCs) expressing pattern 
recognition receptors are thought to be play very important role in early immune response to 
malaria. It has recently been described that P. falciparun derived hemozoin (Coban et al. 2005) 
and parasite derived DNA (Gowda et al. 2011) induce proinflammatory cytokines though toll like 
receptor 9 (TLR9). P. falciparum infected erythrocytes expresses erythrocyte membrane protein 1 
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(PfEMP1), which is recognised via CD36 receptor on phagocytes resulting in the clearance of 
infected erythrocytes by tissue macrophages (Ayi et al. 2005). Severe malaria infection induces 
strongly elevated blood concentrations of non-specific malaria immunoglobulin, but the 
importance of the underlying polyclonal B-cell activation for innate immunity is not understood. 
Acquired Immunity 
People living in holoendemic regions under intense malaria transmission acquire immunity that 
protects against severe clinical manifestations. Anti-malarial immunity, which protect against high 
parasite burden is acquired slowly and not very efficiently and remains species and strain specific. 
Asymptomatic infections are frequent in children and adults in holoendemic regions. The 
equilibrium between host immune response and constant low-parasite burden in patients has 
been termed premunition and it indicates that immunity against malaria is mediated by the 
presence of parasite (COLBOURNE 1955). Repeated malaria infections induces specific and 
polyclonal antibody production, predominately IgG and IgM antibodies. During the first months, 
infants are protected from severe malaria clinical manifestations (Franks et al. 2001) and this 
protection has been associated with passive transfer of maternal antibody IgG (Riley et al. 2001) 
Passive transfer of antibodies from immune patients protects by reducing parasitemia and clinical 
disease. The infants after 5 to 6 months of age become more susceptible to severe malaria and 
severe malarial anaemia is the common clinical symptom. However, during pregnancy, women 
are more susceptible to malaria infections. It is thought that this derives from immune 
suppression during gestation period and sequestration of infected erythrocytes in the placenta 
especially during first and second pregnancy (Menendez 2006). Antibodies against malaria may 
protect by inhibiting merozoite invasion of red blood cell and intra-erythrocytic development of 
the parasite. Opsinization of infected erythrocytes by specific antibodies enhances the clearances 
form the circulation. Malaria parasite escapes from the host’s immune response, due to their 
antigenic diversity and clonal antigenic variation, and also changes the immune response and 
causes considerable amount of immune suppression. The adaptive anti malaria immunity does 
not persist for long time. In the absence of repeated malaria infections, the acquired immunity 
become fruitless and the individual become vulnerable to the malarial infection once again.  
1.12 The complement system 
Complement system is one of the most important and evolutionary highly conserved ancient 
components of the innate immune system. The human complement system consist more than 30 
soluble plasma proteins and membrane associated regulator proteins (Sarma and Ward 2011). 
Plasma contains more than 3 grams of complement proteins per liter and constitutes 15% of 
globulin fraction (Walport 2001). Many complement proteins circulate in the serum as 
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proenzymes and are activated by proteolytic cleavage. Complement components are designated 
by the historical order of the discovery of the proteins: C1-C9, and by letters (e.g. factor D, factor 
B). Complement activation leads to a sequential cascade of enzymatic reactions resulting in 
opsonization of pathogens with C3b and their removal by phagocytes, and by lysis of susceptible 
cells. There are three pathways for activation of the complement cascade, the classical, 
alternative and lectin pathway. All pathways converge at C3 and result in the formation of 
membrane attack complex (C5b-9).  
Classical complement pathway 
The first discovered complement pathway was the classical pathway whose activation occurs only 
after adaptive immune responses have been recruited. Activation of classical pathway begins with 
the formation of antigen-antibody complex (immune complex) or with the binding of antibody to 
a cell surface and end with the lysis of the cell. Binding of specific IgM or IgG (subclasses 1, 2 or 3) 
to antigen induces conformational changes in the Fc region of the antibody molecule and that 
exposes a binding site for C1of the complement component. Antigen-antibody complexes 
containing IgM are more efficient in activating complement than immune complexes containing 
IgG, because IgM is a pentamer. C1 cleaves the C4 into C4a and C4b and the C4b fragment 
attaches to the activator surface in the vicinity of C1 and rapidly followed by C2 binding to 
adjacent C4b, where the C2 is also proleolytically cleaved by C1. The resulting C4bC2a is the 
classical complement pathway C3 convertase. 
Alternative complement pathway 
Alternative pathway is evolutionarily more ancient complement pathway than the two other 
complement activation pathways. Alternative pathway was named because it was identified 
secondary to the classical pathway. Activation of alternative complement pathway does not 
require antibody, so the alternative pathway is a component of the innate immune system. Under 
normal circumstances, the circulating C3 has an unstable thioester bond which is spontaneously 
become activated by reacting with water, and constantly generates C3b at low level in a process 
which can be called as complement pathway “tickoverˮ. This spontaneously generated C3b is 
rapidly inactivated either by interacting factor I using factor H as a cofactor. The spontaneously 
generated C3b can bind to microbial cell surfaces and then initiates the complement activation. 
Factor B is then recruited to the bound C3b on microbial surface, followed by Factor D that 
cleaves C3b-bound factor B. The resulting C3bBb complex on microbial surface is known as 
alternative complement C3 convertase and this complex is stabilized by plasma properdin 
(Kemper et al. 2010) that extends its half-life 6-10 folds. 
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Lectin complement pathway 
Mannose binding lectins (MBL) are proteins that bind to specific carbohydrates on the surface of 
pathogens including yeast, bacteria, parasites and viruses. MBL is an acute phase protein 
produced in inflammatory response. After binding of MBL to the surface of pathogen, MBL 
associated proteins MASP-1 and MASP-2 bind to MBL, and induces cleavage of C4 to C4a and C4b 
and C2 to C2a and C2b. Pathogen surface bound C4bC2a has C3 convertase enzyme activity 
(Turner 1996).  
Three pathways converge at membrane attack complex 
Activation of all three complement pathways leads the formation of terminal C5b-9 or membrane 
attack complex (MAC) on the target cell. Formation of MAC on the target cell membrane enables 
ions and small molecules diffuse freely across the membrane and leads to the cells lysis. Assembly 
of C5b-9 complex in the membrane lipid bilayer of complement activating target cell starts with 
cleave of C5 α to generate C5a and C5b (Tegla et al. 2011). The C5b component is extremely 
unstable and binding of C6 to it stabilizes its activity. Binding of C5b6 to C7 undergoes a structural 
change that exposes a hydrophobic region which enables the C5b67 complex to insert in to the 
phospholipid bilayer. The subsequent interaction of C8 and C9 with C5b67 results in the formation 
of C5b-9 complex and this complex referred to terminal complement complex (Bhakdi and 
Tranum-Jensen 1987). 
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Figure 7. The Three Pathways of Complement: the Classical, Alternative, and Mannose-Binding 
Lectin Pathways. The three complement pathways come together at the point of cleavage of C3. 
The classical pathway is activated by the binding of the C1 complex to antibodies bound to an 
antigen on the surface of a pathogen. Initially, C1s cleaves C4, which binds covalently to the 
bacterial surface, and then cleavage of C2 leads to the formation of a C4b2a, C3 convertase of the 
classical pathway. Activation of mannose-binding lectin pathway is initiated by binding of 
mannose-binding lectin to the mannose groups on the surface of a bacterial cell. The alternative 
pathway is activated by the covalent binding of C3b to the cell-surface and is activated by low-
grade cleavage of C3 in plasma. Binding of factor B to C3b forms a C3bB complex and factor D 
cleaves factor B bound to C3b to form alternative pathway C3 convertase complex, C3bBb, and 
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this complex was stabilized by properdin enzyme. The C3 convertase enzyme complex cleaves 
many molecules of C3 to C3b, and some of this C3b binds to the C4b and C3b in the convertase 
enzymes for forming C5 convertase enzymes of the classical and alternative pathways, 
respectively. This C3b acts as an acceptor site for C5, and initiates the formation of C5b-9 complex 
or membrane-attack complex (MAC). Source: - Walport  MJ, (2001). Complement: First of Two 
Parts.  N Engl J Med, Vol. 344: (14); 1058-66. 
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2. Aim of the study  
The overall aim of the thesis was to investigate complement in severe Plasmodium falciparum 
malaria infections. 
The specific objectives of the different papers were as follows 
 
Paper 1  
In vitro investigation of complement activating entity from Plasmodium falciparum infected 
erythrocytes, and its identification as the digestive vacuole. 
 
Contribution: P.D., S.D.H., and S. Bhakdi performed the laboratory experiments; M.B., K. 
Reifenberg, and C.O. performed the animal experiments; M.T. and C.O. performed the 
immunohistochemistry work; S. Bhakdi and S.C.B. conceived of the project; P.D., S. Bhakdi, K.L., 
and K. Reiss designed the research; P.D., S. Baumeister, K.L., R.U., K. Reiss, and S. Bhakdi analyzed 
the data; and P.D partially involved in the manuscript preparation, and S. Bhakdi wrote the 
manuscript. 
 
Paper 2  
Investigation into the consequences of selective opsonisation of the digestive vacuole on 
polymorphonuclear leukocytes.  
 
Contribution: S. Bhakdi and S.C.B. conceived the project; S.Bhakdi, K.R., and P.D. designed the 
research; P.D. and S. Bhakdi performed the experiments; R.L. performed the electron microscopy; 
S. Bhakdi, P.D., S. Baumeister, K.L., R.U., and K.R. analyzed the data; and P.D partially involved in 
the manuscript preparation, and S. Bhakdi wrote the manuscript. 
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3. DISCUSSION 
3.1 Discussion Paper 1 
There is ample evidence that complement is consumed during malaria infections. The 
complement studies in humans infected with Plasmodium vivax demonstrated that complement 
was depressed in infected patients. The maximum amount of complement was found to be 
consumed between the time of peak fever and within 10 h after the fever (Neva et al. 1974). 
These findings were confirmed with experiments in rhesus monkeys infected with Plasmodium 
coatneyi, and proved that the decline in complement levels was coincided with onset of schizont 
rupture and the degree of parasitemia (Glew et al. 1975). Complement activation has also been 
demonstrated in experimental human malaria (Rosenberg et al. 1990). Recent clinical data shows 
that complement activation takes place in Gambian children with severe malaria infections 
(Helegbe et al. 2007). Experimental infection of mice with plasmodium berghei suggests the role 
of complement activation in cerebral malaria. The C5 deficiency protects mice from cerebral 
malaria (Patel et al. 2008) in which dysregulation of terminal complement sequence is an 
important contributor to the pathogenesis of experimental cerebral malaria (Ramos et al. 2011). 
Hemozoin, which is formed in the digestive vacuole (DV) during intra-erythrocytic stage of the 
parasite, has emerged as a possible trigger of inflammation. This assumption is primarily based on 
the fact that hematin considered to represent as a synthetic analogue of hemozoin (Pagola et al. 
2000) which provokes inflammatory responses in macrophages (Jaramillo et al. 2004; Prato et al. 
2005), and activates the alternate complement pathway (Pawluczkowycz et al. 2007). However, 
when the mature schizont ruptures, the malaria pigment or hemazoin is still encased by the DV 
membrane and it is the organelle rather than free haemozoin that naturally gain contact with the 
host environment (Bannister et al. 2000a; Abkarian et al. 2011).  
Another long standing conundrum in malaria pathophysiology is reduced synthesis and increased 
consumption of most procoagulant factors. Increased prothrombin time and partial 
thromboplastin time is known to occur in fulminant malaria infections (Pukrittayakamee et al. 
1989; Clemens et al. 1994). In severe malaria, a diminished level of factor XII and prekallikrein 
indicates the activation of intrinsic coagulation pathway (Clemens et al. 1994). High 
concentrations of plasma fibrinogen are common in both uncomplicated falciparum infections 
and cerebral malaria. Further, some reports do not support the role coagulation cascade in 
malaria pathogenesis because fibrin is not always found in autopsy studies (Francischetti 2008). 
Recent data describes that P. falciparum-parasitized red blood cells (pRBCs) induce tissue factor 
(TF) expression in endothelial cells and support the assembly of multimolecular coagulation 
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complexes. Autopsy studies on brain endothelium of P. falciparum-infected children, who had 
died from cerebral malaria, showed increased expression of TF (Francischetti et al. 2007). 
Although complement consumption and blood coagulation defects during P falciparum infection 
have been recognized for decades, no single entity of parasite origin has yet been identified that 
might be implicated directly in triggering these events. Rupture of each P. falciparum infected 
erythrocyte is accompanied by release of 16-32 infectious merozoites along with a single DV into 
the circulation. We discovered that DVs, which are liberated in to the blood stream, has the 
capacity to dually activate complement and coagulation cascades.  
The present study emanated from observations that rupture of parasitized red blood cell (pRBC) 
in active non-immune human serum consumed complement and resulted in binding of C3, and 
C5b-9 to the complement activating DV particle, with sparing of merozoites. Naturally liberated, 
purified DVs from the culture supernatants activate complement and coagulation in a dose 
dependent manner. Immunofluorescence staining and ELISA for C5b-9 indicated that C5b-9 is 
present in membrane bound form. Complement activation requires direct contact of DV 
membrane with serum. DVs that had lost their membrane by sonication lost their functional 
properties. Parasitophorous vacuole membrane enclosed merozoite structures (PEMS), in which 
DVS were remained encased with membrane, did not activate the complement. Isolated 
hemozoin crystals were unable to activate complement and coagulation. This was unexpected 
because synthetic hematin, which has identical chemical and physical properties, (Pagola et al. 
2000) activates the alternative complement pathway albeit at very high concentrations 
(Pawluczkowycz et al. 2007).  
Activation of alternative complement pathway is independent of antibody and activation can take 
place on foreign cell surfaces (Atkinson et al. 1991). Complement activating properties depends 
on the capacity of C3b to form covalent bond with reactive functional groups on the foreign cell 
surface and thereby creates the nidus for assembly of the C3 convertase complex. Complement 
regulatory molecules (Medof et al. 1984; Liszewski et al. 1996) protect host cells from 
complement attack, and lack of such regulatory mechanism on microbial cell surface allows 
complement activation (Atkinson et al. 1991). Furthermore, chemical composition of the cell 
surface also protects the cells from complement attack. Sialic acid and sulphated acid 
mucopolysaccharides are the chemical constituents on the cell surface which influence the 
competition between factor B and factor H for the binding site on C3b. The competition between 
factor B and factor H for binding site on C3b determines C3 convertase formation or decay of C3 
convertase (Kazatchkine et al. 1979). Most microbial cells have decreased levels of complement 
regulatory molecules on their cell surface and that decreases affinity of factor H for cell bound 
C3b. Thus, factor B binds to cell surface bound C3b and facilitates alternative complement 
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activation and amplification on microbial surface. In some bacteria, sialic acid is the main chemical 
constituent on the cell surface of group B and C meningococci, Type 3 group B streptococci, and 
K1 Escherichia coli and these bacteria are resistant to alternative complement pathway activation 
(Fearon and Austen 1980). 
Currently there is not much information available on the chemical composition and organisation 
of the DV membrane. In Plasmodium falciparum, the haemozoin crystal formation takes place 
within the neutral lipid droplets inside the DV (Pisciotta et al. 2007). The hemozoin crystals and 
the lipid bodies are encased within the DV membrane. When DVs were treated with 
phospholipase C, they lost their procoagulant activity but not the complement activating 
properties. It is likely that assembly of multimolecular complex of clotting enzymes is generally 
triggered by Ca2+ bridged interactions with negatively charged phospholipid head groups. 
Activation of clotting cascade with DVs does not depend on any interaction with blood platelets 
and it was triggered in platelet-free plasma. DVs directly activate the thrombin generation with 
purified FXa and prothrombin and DVs replace phospholipid vesicles in the reaction mixture. 
We further investigated whether isolated DVs from P. falciparum had the capacity to activate 
complement of other species. When DVs were injected into rat tail veins, complement was 
consumed within minutes after injection and all the animals became lethargic and behavioural 
changes were observed. The effects of DV infusions were transient, similar to that of 
lipopolysaccharide injection, which also induces systemic inflammatory responses and 
complement activation (Smedegård et al. 1989). Termination of the systemic inflammatory 
responses to DVs might be explained by their rapid clearance by phagocytic cells. Indeed, 
phagocytic cells were rarely seen in the bloodstream of the animals, and the uptake of all the DVs 
by tissue phagocytes was impressive.  
If the major tenets of our hypothesis turn out to be correct, strategies to inhibit DV-dependent 
activation of complement and coagulation might have therapeutic potential. Low molecular 
weight dextran sulfate (LMW-DXS) is known to inhibit complement (Wuillemin et al. 1997) and 
coagulation pathways (Wuillemin et al. 1996; Anderson et al. 2001) at micromolar concentration, 
which does not induce bleeding complications and well tolerated in humans(Johansson et al. 
2006; Schmidt et al. 2008). Indeed, LMW-DXS protected the rats from the harmful effects at very 
high doses of DV injection and caused no side effects in the animals. The LMW-DXS was applied at 
the same concentrations that have been used previously in transplantation models (Wuillemin et 
al. 1997). It has also been reported that LMW-DXS suppress merozoite re-invasion (Clark et al. 
1997). So, the use of LMW-DXS may simultaneously fulfill dual beneficial functions. 
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3.2 Discussion Paper 2 
Phagocytosis of microorganisms by polymorphonuclear granulocytes (PMN), monocytes and 
tissue macrophages is a major mechanism in the innate host defence against microbial infections. 
Phagocyosis is a two-step process implicating attachment and engulfment of phagocytic particle. 
Serum factors called opsonins enhance the rate of uptake of microorganism by binding specifically 
to the receptor on the surface of phagocytes on the one hand and to the microbes on the other. 
This type of phagocytosis is called opsonophagocytosis (Ofek and Sharon 1988). Two types of 
opsonins have been identified, the C3b and C3bi fragments of the third component of the 
complement (C3), and the antibodies, usually immunoglobulin G (IgG) molecules. 
Opsonophagocytosis can take place in three different modes. In the first, only antibody 
participates by binding to surface antigen on the microorganisms and to the corresponding Fc 
receptors on the phagocytes. In the second mode, only the C3b or C3bi fragment of complement 
binds to the activated microbial surface and to the phagocyte surface via specific complement 
receptors. The third one, antigen-antibody complex activates the complement of classical 
pathway and facilitates the deposition of C3b onto the microbial surface. The phagocytic particle 
which are now coated with both the opsonins bind to  both receptors on the phagocytes and 
enhances much stronger binding than that with either antibody or the fragments of C3 alone 
(Ofek and Sharon 1988). Some microorganisms are phagocytosed by neutrophils in the absence of 
opsonins. This type of ingestion is facilitated by recognition of specific sugars on one or both the 
cells. This type phagocytosis is termed as lectinophagocytosis (Ofek and Sharon 1988). However, 
most microorganisms must be coated with opsonins for phagocytosis by neutrophils.  
Phagocytic cells play a vital role in innate immune host defence against malaria. Circulating 
neutrophils, monocytes and tissue macrophages are involved in the clearance of malaria pigment 
(hemozoin), parasitized and nonparasitized RBCs that are ingested by the phagocytes (Vernes 
1980; Facer and Brown 1981; Sun and Chakrabarti 1985; Laing and Wilson 1972). In vitro 
phagocytosis of schizont-infected RBCs by monocytes and macrophages were markedly increased 
in the presence of immune serum (Abdalla and Weatherall 1982; Celada et al. 1983; Celada et al. 
1982; Abdalla 1987). The interaction of phagocytic CD36 with Pf EMP1 has also been implicated in 
the clearance of infected RBC by monocytes and macrophages in humans (Ayi et al. 2005) and 
also in rodent malaria (Su et al. 2002). There is scant information on the role of PMN in malaria 
infections. Malaria pigment is microscopically detectable in the circulating polymorphonuclear 
granulocytes (PMN) of malaria patients, and there is a positive correlation between the number of 
circulating pigment-containing PMN and severity of the disease (Nguyen et al. 1995; Lyke et al. 
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2003). Although, the malaria pigment is detectable in circulating PMN, the question how the 
pigment enters the cell has never been described.  
Another long standing enigma in malaria pathophysiology is that children from African countries 
with fever – often suffer from invasive bacterial infections (Were et al. 2011; Bronzan et al. 2007). 
Accumulated evidence from sub-Saharan African countries, where malaria is endemic, 
demonstrates that non-typhoidal Salmonellae (NTS) infections are the most common bacterial 
infections associated with elevated paediatric morbidity and mortality (Mabey et al. 1987; Berkley 
et al. 1999; Bronzan et al. 2007; Were et al. 2011). Current hypotheses regarding the causes 
underlying this general state of immune suppression focus mainly on the functional disturbances 
of macrophages, dendritic cells and the adaptive immune system.  
Rupture of each parasitized erythrocyte in P. falciparum malaria liberates one DV alongside with 
16-32 infectious merozoite into the bloodstream which invade new RBC for further cycle 
(Bannister et al. 2000b; Abkarian et al. 2011). High parasitemia is thus inseparably associated with 
high loads of DVs at the sites of pRBC rupture. Arese et al group has been conducting studies with 
naturally released DVs, and mainly focused on their effects on monocyte functions (Schwarzer et 
al. 1992; Skorokhod et al. 2004; Prato et al. 2010). Isolated hemozoin pigment provoked a 
respiratory burst after ingestion and the production of respiratory burst was blunted upon 
subsequent provocation. Later on, Fiori et al showed that monocytes fed with mature infected 
erythrocytes have reduced microbial activities (Fiori et al. 1993). The fact that most DVs will 
probably be ingested not by tissue macrophages rather by the surrounding PMN has never been 
considered prior to the present work, an oversight that likely derives from several reasons. There 
is a tacit assumption that the malaria pigment itself is endowed with biological properties and 
synthetic hematin which is considered identical to natural malaria pigment hemozoin (Pagola et 
al. 2000; Bohle et al. 2002).  
Binding of C3b complement marks DV particle for phagocytosis. When DVs were marked with C3b 
opsonin in active serum they were found to be rapidly phagocytosed by PMN. This raised the 
possibility that ingestion of DVs explains the major pathway leading to the presence of malaria 
pigment in PMN of malaria patients. However, sonicated DVs or purified hemozoin crystals 
incubated with PMN in the presence of complement did not induce any respiratory burst and 
were not engulfed by the PMN. We also could not find any phagocytosis of schizonts in non-
immune serum. We propose that hemazoin pigment in PMN of malaria patients derive mainly 
from phagocytosis of C3b complement marked intact DVs following schizont rupture. Previously 
described electron microscopic pictures of both PMN and macrophages containing malarial 
pigment (Wickramasinghe et al. 1987) are highly suggestive for two reasons. First, although the 
cells had not phagocytosed intact schizonts, aggregated haemozoin crystals could be readily seen 
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in the cell cytoplasm. Such aggregates do not persist when the pigment is artificially liberated 
from the organelle in vitro. Second, the aggregated hemozoin crystals can be seen to be 
surrounded by membrane structures in the electron micrographs. These findings are fully in line 
with our hypothesis that phagocytosis of DVs underlies the appearance of malaria pigment in the 
cells. 
In the next experiment we investigated whether DVs might be preferentially phagocytosed by 
PMN in the presence and absence of high-titered antibodies against P. falciparum. Schizonts were 
allowed to rupture in the presence of active instead of heat-inactivated serum so that 
complement activation would immediately occur upon erythrocyte rupture. Merozoite DNA was 
stained with Hoechst prior to addition of surface-stained PMN, rendering rapid fluorescent 
microscopic analysis feasible. These experiments revealed the striking fact that DVs but not 
merozoites were selectively marked by complement and phagocytosed in the presence of active, 
non-immune serum. In the presence of high-titered antibodies against P. falciparum phagocytosis 
of both DVs and merozoites were observed. However, preferential uptake of DVs still appeared to 
persist. Thus, despite the fact that as occurs in vivo, merozoites outnumbered DVs by an order of 
magnitude, PMN were never observed to contain merozoites only. If preferential uptake of DVs 
really takes place, this might impinge on each cell's capacity to ingest merozoites. 
The oxidative or respiratory burst plays a vital role in the microbicidal machinery of mammalian 
phagocytes which degrades internalized particles and bacteria (Jandl et al. 1978; Lee et al. 2000). 
ROS generation by phagocytosed DVs might therefore be followed by a state of 
hyporesponsiveness.  Experiments with murine malaria have been reported that merozoites were 
susceptible to the cytotoxic action of ROS. It was of interest to determine whether ROS 
production might serve a protective function by killing bystander parasites, therefore enriched 
late-stage schizonts were incubated with ten-fold excess of non-infected RBCs in the presence or 
absence of PMN, ROS produced by PMN after ingestion of DVs led to no reduction of merozoite 
invasion. We further investigated that the capacity to mount ROS production upon subsequent 
bacterial challenge was severely compromised following DV uptake by PMN. Challenging of PMN 
with bacteria after ingestion of DVs still has the capacity to phagocytose bacteria. However, PMN 
preloaded with DVs had reduced microbicidal activity.  
Thus, having served its physiological purpose, the liberated DVs after schizont rupture appears to 
function as a decoy, and is exploited by the parasite to divert and perturb central elements of the 
innate immune system. The alternative complement pathway and intrinsic clotting are 
simultaneously activated by the DV surface (Dasari et al. 2012). The preferential phagocytosis of 
DVs by blood phagocytes initially may provide beneficial function to the host by restricting 
activation of complement and coagulation. But in the long run, as parasitemia increases, there will 
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be detraction of the phagocytes away from their true targets. This might lead to over activation of 
ancient enzyme cascades by DVs which provides inflammatory mediators to contribute to the 
development of severe malaria. We found that high-titered P. falciparum specific antibodies 
induce some phagocytosis of merozoites. Possibly because efficient engulfment of DVs by PMN is 
still prevalent, PMN ingested only a small amount of merozoites and the majority of parasites 
remained outside the cell. In accord with this observation, there were no substantive reductions 
in the rate of merozoite re-invasion. However, our findings accorded with earlier reports in which 
little (Kumaratilake et al. 1990) or no protective effects of specific antibodies against P. falciparum 
plus PMN could be observed in vitro (Kumaratilake and Ferrante 2000; Kumaratilake et al. 1990). 
Monocytes apparently synergized more efficiently with the antibodies (Bouharoun-Tayoun et al. 
1990), but the significance of this finding remains unclear since the cells were employed at 
unphysiologically high numbers. Most recently, it has been reported that the presence of specific 
antibodies induced strong ROS responses in PMN upon incubation with a mix of merozoites and 
DVs was reported to correlate with better in vivo protection compared with antibodies that 
induced little ROS production (Joos et al. 2010).  
DV uptake and cellular activation could cause PMN to remain mainly sequestered in the 
microcirculation. Then, the actual number of DV-laden phagocytes would probably be 
considerably higher than suggested by the mere numbers of circulating hemozoin-containing 
cells. Sequestered, activated PMN possibly augment pathological processes in the 
microcirculation. At the same time, their systemic overloading may gradually set the stage for 
septicemic complications to develop whenever bacterial pathogens chance to gain entry into the 
circulation. The leading roles played by Salmonellae and Enterobacteriaceae in African children 
may derive simply from the high endemic prevalence of these agents. 
 
3.3 Conclusion 
In conclusion, digestive vacuoles released into the blood stream after schizont rupture had the 
capacity to activate both complement and coagulation. The digestive vacuole is a membrane 
bound organelle packed with the malaria pigment hemozoin which gains the contact with the 
host environment. Sonicated DVs lost its complement-activating and procoagulant biologically 
properties in vivo and in vitro. Procoagulant property of DVs was destroyed by phospholipase-C 
treatment. Purified hemozoin was unable to activate complement and coagulation. Intravenous 
injection of DVs into the rats induced alternative pathway complement activation and provoked 
apathy and reduced nociceptive responses. Complement and coagulation properties were 
blocked by low-molecular weight dextran sulfate and protected animals from the deleterious 
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effects of DV infusion. In the presence of active non-immune serum, DVs but not the merozoites 
were selectively opsonised by C3b and rapidly phagocytosed by PMN. High titered antibodies 
against Plasmodium falciparum induced phagocytosis of both DVs and merozoites, but the 
preferential engulfment was DVs than merozoites. Late stage schizonts and purified hemazoin 
crystals were not phagocytosed by PMN. Isolated DVs rapidly phagocytosed by PMN and drove 
the cells in a state of functional exhaustion. Phagocytosed DVs induced ROS production in PMN, 
and the ROS production was diminished with subsequent challenging of PMN with S. aureus. DV 
phagocytosed PMN effectively engulfed S. aureus, but the micobicidal activity was compromised. 
Together, the studies indicate that the DV may represent a novel determinant of parasitic 
pathogenicity that can simultaneously compromise the coagulation and the innate immune 
system. 
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